http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100818047-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100818047-B1 |
| titleOfInvention | A method for promoting the death of cancer cells by inhibiting the activity of smooth muscle-22α and an anticancer agent comprising an activity inhibitor of smooth muscle-22α as an active ingredient |
| abstract | The present invention relates to a method for promoting the death of cancer cells by inhibiting the activity of smooth muscle-22α and an anticancer agent comprising an activity inhibitor of smooth muscle-22α as an active ingredient. Antisense nucleotides that complementarily bind to smooth muscle-22α mRNA, peptide mimetics that bind smooth muscle-22α protein, and an activity inhibitor selected from the group consisting of antibodies. The method of inhibiting the activity of smooth muscle-22α and the inhibitor of the present invention can be usefully used for anticancer treatment by promoting the cell killing effect of cancer cells.n n n n Smooth muscle-22 alpha, an anticancer agent |
| priorityDate | 2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.